Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hesham Nasser

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical & Translational Immunology|August 17, 2019
Expression of IL-34 correlates with macrophage infiltration and prognosis of diffuse large B-cell lymphomaOsamu Noyori, Yoshihiro Komohara, Hesham Nasser, et al.
Plos Pathogens|November 30, 2018
Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophagesRokeya Siddiqui, Shinya Suzu, Mikinori Ueno, et al.
Nature Communications|December 14, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Sayaka Deguchi, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Jumpei Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2015
Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1Michihiro Hashimoto, Hesham Nasser, Farzana Bhuyan, et al.
Cell Host & Microbe|June 25, 2021
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivityChihiro Motozono, Mako Toyoda, Jiri Zahradnik, et al.
Iscience|December 12, 2022
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variantIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Nature|February 1, 2022
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Journal of Virology|October 5, 2023
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristicsIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Cell Host & Microbe|January 27, 2024
Virological characteristics of the SARS-CoV-2 BA.2.86 variantTomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical & Translational Immunology|August 17, 2019
Expression of IL-34 correlates with macrophage infiltration and prognosis of diffuse large B-cell lymphomaOsamu Noyori, Yoshihiro Komohara, Hesham Nasser, et al.
Plos Pathogens|November 30, 2018
Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophagesRokeya Siddiqui, Shinya Suzu, Mikinori Ueno, et al.
Nature Communications|December 14, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Sayaka Deguchi, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
A non-spike nucleocapsid R204P mutation in SARS-CoV-2 Omicron XEC enhances inflammation and pathogenicityShuhei Tsujino, Masumi Tsuda, Jumpei Ito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2015
Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1Michihiro Hashimoto, Hesham Nasser, Farzana Bhuyan, et al.
Cell Host & Microbe|June 25, 2021
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivityChihiro Motozono, Mako Toyoda, Jiri Zahradnik, et al.
Iscience|December 12, 2022
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variantIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Nature|February 1, 2022
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantRigel Suzuki, Daichi Yamasoba, Izumi Kimura, et al.
Journal of Virology|October 5, 2023
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristicsIzumi Kimura, Daichi Yamasoba, Hesham Nasser, et al.
Cell Host & Microbe|January 27, 2024
Virological characteristics of the SARS-CoV-2 BA.2.86 variantTomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Pageof 4